Market Tracker

05/27 5:16pm ET

Nektar Therapeutics (NASDAQ:NKTR)

15.17
Delayed Data
As of May 27
 +0.27 / +1.81%
Today’s Change
9.16
Today|||52-Week Range
17.55
-9.97%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close14.90
Today’s open14.96
Day’s range14.87 - 15.29
Volume810,475
Average volume (3 months)1,358,913
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-52.93%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book319.23

Competitors

 Today’s
change
Today’s
% change
INCRINC Research Holding...+0.21+0.47%
DBVTDBV Technologies SA+0.29+0.90%
ARIAARIAD Pharmaceutical...+0.18+2.24%
IONSIonis Pharmaceutical...+0.64+3.02%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts